Supplements & Liver Injury: What AARP Didn’t Tell You

Yes, Some Supplements Can Affect the Liver — Here’s the Context AARP Left Out

AARP’s recent piece, “10 Popular Supplements Linked to Serious Liver Injury,” is built on real data. The NIH’s Drug-Induced Liver Injury Network (DILIN) has documented cases of hepatotoxicity associated with certain botanicals, weight-loss compounds, and bodybuilding products. I’m not going to tell you that research doesn’t exist. I’m an attorney, an educator, and someone who has spent two decades in this industry, and I’ll tell you the same thing I tell everyone: the studies are real, but the way mainstream media presents them is almost always stripped of the one variable that actually matters — dose, duration, and individual context.

This is the pattern every single time a supplement liver story runs. A legitimate signal from a case series gets inflated into a blanket “these products are dangerous” narrative, with zero mention of dosage, product quality, concurrent alcohol or medication use, or how the risk profile compares to substances already sitting in your medicine cabinet. Let’s fix that.

What the Research Actually Shows

The foundational study AARP and similar outlets lean on is Navarro et al., published in Hepatology (2017), which analyzed the DILIN registry and found that herbal and dietary supplements accounted for roughly 20% of drug-induced liver injury cases in the U.S. — up from about 7% a decade earlier. That’s a legitimate finding worth taking seriously. But read the actual paper, not the headline: the implicated products were overwhelmingly unregulated bodybuilding supplements adulterated with anabolic steroids, certain weight-loss blends containing undisclosed stimulant stacks, and specific botanicals like green tea extract concentrates and kava taken in high, unsupervised doses over extended periods.

This is Law #1 of biochemistry physics: the Law of Dose Response. Everything is dose-dependent. Water itself causes fatal hyponatremia at excessive intake. The Navarro data doesn’t indict a category of molecules — it indicts unsupervised mega-dosing of adulterated or poorly characterized products, frequently without any bloodwork, cycling protocol, or medical oversight. That’s not a supplement problem. That’s an education and quality-control problem.

The Products Actually Named Matter

Look closely at the DILIN case series and similar studies, like Chalasani et al.’s follow-up work in Gastroenterology (2015) on the causes and outcomes of DILI, and you’ll find the injury reports cluster around specific failure points: unregulated gray-market products with no third-party testing, megadosed green tea catechin extracts (often 10x what’s found in brewed tea), and combination “proprietary blend” fat burners where consumers had no idea what dose of what compound they were actually consuming. That’s not an argument against supplementation — it’s an argument for transparency, testing, and individualized protocols.

The Individual Variation Factor

Law #2: the Law of Individual Variation. Every liver injury case series ever published shows massive variability in who gets hurt and who doesn’t. Genetic polymorphisms in cytochrome P450 enzymes (CYP2D6, CYP3A4) determine how efficiently your liver metabolizes a given compound. Two people can take the identical dose of the identical product, and one develops elevated liver enzymes while the other shows nothing. This is well established in pharmacogenomic literature, including work published in Clinical Pharmacology & Therapeutics on CYP450 variant carriers and adverse drug reactions.

Cookie-cutter blanket warnings — “these 10 supplements cause liver injury” — completely ignore this. Body composition, existing liver function, alcohol consumption, concurrent medications, gut microbiome composition, and genetic metabolic capacity all determine individual risk. This is why personalized protocols, baseline bloodwork, and periodic liver panel monitoring matter infinitely more than a prohibition list.

The Comparison Nobody Wants to Print

Here’s what never makes it into these articles: acetaminophen (Tylenol) is the single leading cause of acute liver failure in the United States, full stop. Larson et al., published in Hepatology (2005), documented that acetaminophen toxicity accounted for approximately 39% of all acute liver failure cases in a U.S. multicenter prospective study — and that was two decades ago, before the numbers climbed further. The FDA itself has repeatedly flagged acetaminophen-related liver failure as a leading cause of emergency transplant listings.

Nobody is writing viral AARP articles telling grandparents to throw out their Tylenol. Nobody is running “10 Popular Painkillers Linked to Serious Liver Injury” segments on morning television. Alcohol, an FDA-unregulated, socially normalized substance, is a documented direct hepatotoxin responsible for alcoholic liver disease affecting millions of Americans, per CDC and NIAAA data. Statins, a category of prescription medication taken by tens of millions of Americans daily, carry FDA-mandated liver enzyme monitoring warnings on their own labels.

This is Law #4: the Law of Side Effect Inevitability. Every intervention — pharmaceutical, herbal, over-the-counter, or otherwise — carries trade-offs. Informed consent means knowing the full risk landscape, not just the risk landscape of the substances the media has decided to demonize this quarter.

Risk in Context

None of this means supplement-related liver injury isn’t real or worth monitoring. It means the risk needs to be weighed against known, accepted baselines — not presented in a vacuum designed to generate fear clicks for an audience already skeptical of anything outside pharmaceutical orthodoxy.

Diminishing Returns: Why Abuse, Not Use, Is the Actual Variable

Law #3: the Law of Diminishing Returns. More is never better past a certain threshold — and this is exactly why the case reports driving these headlines involve people megadosing unregulated products with no cycling structure, no bloodwork, and no exit strategy. Optimization beats maximization every single time. Educated, cycled, monitored supplementation with quality-tested products consistently outperforms both total abstinence (which leaves people at the mercy of pharmaceutical-only options) and reckless abuse (which is what actually generates the case studies AARP is citing).

The DILIN registry data doesn’t distinguish well between someone taking a quality-controlled product at a reasonable dose with periodic bloodwork, and someone chain-dosing an adulterated gray-market powder for six months straight with zero monitoring. The media coverage collapses that distinction entirely. We shouldn’t.

Biological Momentum and Why “Just Stop Taking It” Isn’t the Answer

Law #5: the Law of Biological Momentum. The body resists rapid change and seeks homeostasis. This is precisely why cycling protocols, post-cycle recalibration, and gradual introduction/discontinuation of any substance — supplement or pharmaceutical — matter more than binary “take it or don’t” thinking. Uninformed advice to simply stop cold, without a structured approach or a doctor who actually understands hepatic adaptation, frequently produces worse outcomes than a monitored, educated protocol would have in the first place.

What They Don’t Tell You

• Source matters enormously. The DILIN and Navarro studies overwhelmingly implicate unregulated, non-third-party-tested products — not the entire category of dietary supplements broadly.
• Reversibility is common. Multiple case series, including follow-up data published in the Journal of Clinical and Translational Hepatology, show that the majority of supplement-associated liver enzyme elevations resolve upon discontinuation, without progression to permanent damage.
• Denominator data is missing. Articles cite raw case counts without contextualizing them against the tens of millions of Americans using these products daily without incident — a basic epidemiological omission that inflates perceived risk.
• Nobody mentions baseline liver monitoring. A simple periodic liver panel through any qualified healthcare provider catches issues early, long before they become the case report headline.
• Comparative risk is never disclosed. Acetaminophen, alcohol, and multiple FDA-approved prescription medications carry documented hepatotoxicity risks equal to or exceeding many of the products named — yet only supplements get the fear-based headline treatment.

Medical Freedom Means Full Information, Not Prohibition

I’m not telling you to ignore liver health. I’m telling you the AARP article, like most mainstream supplement coverage, gives you half the picture and calls it complete. The actual peer-reviewed research supports a nuanced conclusion: dose matters, product quality matters, individual genetics matter, and monitoring matters — none of which fits into a scary top-10 listicle format.

Body autonomy means having access to the full research landscape, not a curated fear narrative designed to push you back toward pharmaceutical-only solutions that carry their own well-documented hepatotoxicity risks. Always consult a qualified healthcare provider before starting or modifying any supplementation protocol, get baseline and periodic bloodwork, and source products from companies that publish third-party testing.

The system profits when you’re afraid to ask questions. Education is the actual harm reduction tool here — not prohibition, not fear, and not selectively presented statistics. For deeper breakdowns of the peer-reviewed research behind performance and health optimization — including the full framework behind the 5 laws of biochemistry physics — go to tonyhuge.is.